TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the " Company "), a specialty pharmaceutical company focused on the reformulation of established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback